Skip to content

Clinical trials

Feeding and Eating Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Feeding and Eating Disorders Country / region: Canada Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20091
20102
20121
20131
20143
20153
20161
20171
20182
20201
20217
20224
20233
20242
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting6
Unknown status4
Terminated3
Not yet recruiting3
Withdrawn1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
McMaster University7
Nova Scotia Health Authority7
Laval University3
University Health Network, Toronto3
Douglas Mental Health University Institute2
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2
New York State Psychiatric Institute2
St. Joseph's Healthcare Hamilton2
Aaron Keshen1
Children's Hospital of Eastern Ontario1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Feeding and Eating Disorders41
Anorexia Nervosa9
Bulimia Nervosa8
Binge-Eating Disorder5
Bulimia3
Mental Disorders3
Obesity3
Alzheimer Disease2
Attention Deficit Disorder with Hyperactivity2
Diabetes Mellitus, Type 12

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.